Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CalciMo-TP: CNI Monitoring in Lung Transplant
NCT02897895Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Dec 2016
- Primary completion
- Dec 2021
- Modality
- Peptides, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of cyclosporine and tacrolimus in lung transplant rejection (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: number of episodes of acute rejection after LTx at 6 months. Status: unknown.
02
Drugs
cyclosporinetacrolimus
03
Conditions
lung transplant rejection
Beyond the preview
Go deeper on NCT02897895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02897895.